In this article, "Creating an IPO Alternative for Small Biotechs," the second in a four-part series published in BioWorld Insight on November 14, 2011, Mintz Levin attorney William C. Hicks is quoted discussing two of the four bills making their way through congress that could have a significant impact on funding for biotechs.
To read the article in full, click here.